HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 138 filers reported holding HALOZYME THERAPEUTICS INC in Q1 2015. The put-call ratio across all filers is 0.70 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $678,063 | -53.0% | 17,755 | -30.0% | 0.00% | -55.6% |
| Q4 2022 | $1,444,122 | +8.9% | 25,380 | -24.3% | 0.01% | 0.0% |
| Q3 2022 | $1,326,000 | -10.2% | 33,544 | 0.0% | 0.01% | -10.0% |
| Q2 2022 | $1,476,000 | +10.3% | 33,544 | +0.0% | 0.01% | +42.9% |
| Q1 2022 | $1,338,000 | -0.8% | 33,540 | 0.0% | 0.01% | 0.0% |
| Q4 2021 | $1,349,000 | -1.8% | 33,540 | -0.7% | 0.01% | 0.0% |
| Q3 2021 | $1,374,000 | -10.4% | 33,781 | 0.0% | 0.01% | -12.5% |
| Q2 2021 | $1,534,000 | -22.7% | 33,781 | -29.0% | 0.01% | -27.3% |
| Q1 2021 | $1,984,000 | -6.9% | 47,580 | -4.6% | 0.01% | -15.4% |
| Q4 2020 | $2,131,000 | +22.3% | 49,888 | -24.8% | 0.01% | +18.2% |
| Q3 2020 | $1,743,000 | -77.6% | 66,342 | -77.1% | 0.01% | -78.0% |
| Q2 2020 | $7,774,000 | -49.2% | 289,970 | -65.9% | 0.05% | -53.7% |
| Q1 2020 | $15,289,000 | -36.3% | 849,865 | -37.2% | 0.11% | -0.9% |
| Q4 2019 | $23,988,000 | +24.3% | 1,352,941 | +8.7% | 0.11% | +22.5% |
| Q3 2019 | $19,305,000 | -14.2% | 1,244,666 | -5.0% | 0.09% | -11.9% |
| Q2 2019 | $22,505,000 | +13.8% | 1,309,959 | +6.6% | 0.10% | +14.8% |
| Q1 2019 | $19,777,000 | +35.2% | 1,228,380 | +22.8% | 0.09% | +29.4% |
| Q4 2018 | $14,631,000 | -18.5% | 1,000,059 | +1.2% | 0.07% | 0.0% |
| Q3 2018 | $17,950,000 | +21.1% | 987,867 | +12.4% | 0.07% | +15.3% |
| Q2 2018 | $14,825,000 | +3.1% | 878,779 | +19.8% | 0.06% | +3.5% |
| Q1 2018 | $14,374,000 | -12.9% | 733,767 | -9.9% | 0.06% | -8.1% |
| Q4 2017 | $16,497,000 | +10.9% | 814,242 | -4.9% | 0.06% | +5.1% |
| Q3 2017 | $14,879,000 | +32.0% | 856,579 | -2.6% | 0.06% | +31.1% |
| Q2 2017 | $11,272,000 | -1.2% | 879,243 | -0.1% | 0.04% | -6.2% |
| Q1 2017 | $11,409,000 | +34.9% | 880,358 | +2.8% | 0.05% | +23.1% |
| Q4 2016 | $8,457,000 | -12.2% | 856,007 | +7.4% | 0.04% | -15.2% |
| Q3 2016 | $9,629,000 | +13.3% | 797,081 | -19.1% | 0.05% | +9.5% |
| Q2 2016 | $8,498,000 | +20.8% | 984,723 | +32.6% | 0.04% | +20.0% |
| Q1 2016 | $7,032,000 | -36.9% | 742,510 | +15.5% | 0.04% | -36.4% |
| Q4 2015 | $11,145,000 | +38.7% | 643,114 | +7.5% | 0.06% | +31.0% |
| Q3 2015 | $8,034,000 | -39.3% | 598,213 | +2.0% | 0.04% | -36.4% |
| Q2 2015 | $13,236,000 | +48.6% | 586,200 | -6.0% | 0.07% | +46.7% |
| Q1 2015 | $8,907,000 | +84.8% | 623,762 | +24.9% | 0.04% | +80.0% |
| Q4 2014 | $4,819,000 | +12.3% | 499,410 | +5.9% | 0.02% | +19.0% |
| Q3 2014 | $4,291,000 | -10.6% | 471,484 | -2.9% | 0.02% | -8.7% |
| Q2 2014 | $4,799,000 | +26.6% | 485,745 | +62.8% | 0.02% | +27.8% |
| Q1 2014 | $3,790,000 | -0.9% | 298,391 | +16.9% | 0.02% | 0.0% |
| Q4 2013 | $3,825,000 | +1170.8% | 255,191 | +835.5% | 0.02% | +1700.0% |
| Q3 2013 | $301,000 | +39.4% | 27,278 | 0.0% | 0.00% | 0.0% |
| Q2 2013 | $216,000 | – | 27,278 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRAN CAPITAL MANAGEMENT, L.P. | 1,506,473 | $61,283,000 | 5.13% |
| First Light Asset Management, LLC | 1,477,496 | $60,105,000 | 3.96% |
| SNYDER CAPITAL MANAGEMENT L P | 3,427,476 | $139,430,000 | 3.69% |
| DOHENY ASSET MANAGEMENT /CA | 80,400 | $3,271,000 | 2.34% |
| Redwood Investments, LLC | 619,766 | $25,212,000 | 2.11% |
| HighMark Wealth Management LLC | 53,341 | $2,170,000 | 1.60% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 60,170 | $2,448,000 | 1.38% |
| Third Security, LLC | 168,604 | $6,859,000 | 1.33% |
| Taylor Wealth Management Partners | 87,654 | $3,566,000 | 1.27% |
| Penn Capital Management Company, LLC | 290,394 | $11,813,000 | 1.19% |